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KEYNOTE SPEECH ON THE
APPLICATION OF HARM REDUCTION
TO OTHER PUBLIC HEALTH
PROBLEMS: WHAT IS SIMILAR OR
DIFFERENT ABOUT THE ISSUE OF
TOBACCO?
CHERYL HEALTON*
Good afternoon everyone. Today our focus is on "reduced harm" tobacco
products-the brands, old and new, that the industry brings to the market because
these products allegedly cause less harm to consumers than traditional tobacco
products. All of us who are dedicated to tobacco control and improving public
health are automatically suspicious of these types of products. But, unfortunately, it
appears that the general public does not share our suspicion, and therein lays the
rub. Having been misled by the tobacco industry for decades, we come to this
debate as what one could call "jaded" or just "historically informed." I think Judge
Gladys Kessler in her much-anticipated final opinion in United States v. Philip
Morris USA, Inc. put it best:
[O]ver the course of more than 50 years, [d]efendants lied,
misrepresented, and deceived the American public, including smokers
and the young people they avidly sought as "replacement smokers,"
about the devastating health effects of smoking and environmental
tobacco smoke, they suppressed research, they destroyed documents,
they manipulated the use of nicotine so as to increase and perpetuate
addiction, they distorted the truth about low tar and light cigarettes so as
to discourage smokers from quitting, and they abused the legal system
in order to achieve their goal-to make money with little, if any, regard
for individual illness and suffering, soaring health costs, or the integrity
of the legal system.'
It is a stinging indictment of the tobacco industry and one that surprised few
of us.
Copyright © 2008 by Cheryl Healton.
*President and CEO, American Legacy Foundation.
1. 449 F. Supp. 2d 1,852 (D.D.C. 2006).
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At the American Legacy Foundation, we know a great deal about the tobacco
industry's effort to distort and squelch the truth. We were finally-and
unanimously-vindicated in the summer of 2006 by the Delaware Supreme Court
in our long and costly five-year battle with Lorillard Tobacco, a company that had
been aiming to shut down the Foundation and make it no longer possible for us to
tell youth the truth about tobacco and the way it is marketed to them.2 While we
produced ads using content directly from Lorillard Tobacco's own documents, they
argued that truth® vilified and personally attacked them, a violation of the
landmark 1998 Master Settlement Agreement (MSA).3
The American Legacy Foundation was established as a public health
foundation devoted to educating the nation about tobacco, with the intent of
preventing young people from starting to smoke and helping those 45 million adult
Americans who are still smoking by steering them to viable methods for cessation.4
Our truth® campaign has been credited with 22% of the decline that has occurred
in youth smoking during its first two years, 5 and studies from 2002 to 2004 do not
report an increase in tobacco use among youth.6 The campaign works and the
tobacco industry has worked aggressively to silence it. Thankfully, the industry's
efforts have failed, and we intend to stay the course and save lives. To do so, we
will continue to generate debate among youth about tobacco and how it is marketed
to them. truth® never tells kids not to smoke, but instead educates them to be wary,
savvy consumers and lets them make their own choice about whether they want to
take up this habit.
For adults, the debate gets more complicated because for the majority of adult
smokers-and many of you know I was one-smoking is not about choice but very
much about addiction. To a smoker addicted to nicotine, a reduced harm product in
any form, whether it's a new filter, whether it's called "light," "ultra light," "mild,"
or whether it's one of the plethora of potential reduced exposure products (PREPs)
in the offing, the response is: "Well, maybe this one isn't so bad for me," or "It
must be safer." In fact, in a study from a sample of about 700 individuals in the
United Kingdom, approximately 70% of smokers, regardless of their position in the
stages of change (including those just about ready to quit), wanted to try PREPs
2. Lorillard Tobacco Co. v. Am. Legacy Found., 903 A.2d 728, 731, 745 (Del. 2006).
3. Id. at 731.
4. Am. Legacy Found., About Us: Overview, http://www.americanlegacy.org/72.htm (last visited
Jan. 8, 2008); Am. Legacy Found., Statement by the American Legacy Foundation on Adult Smoking
Rates, http://www.americanlegacy.org/701.html (last visited Jan. 8, 2008).
5. Matthew C. Farrelly et al., Evidence of a Dose-Response Relationship Between "truth"
Antismoking Ads and Youth Smoking Prevalence, 95 AM. J. PUB. HEALTH 425, 428 (2005).
6. See Ctrs. for Disease Control & Prevention, Tobacco Use, Access, and Exposure to Tobacco in
Media Among Middle and High School Students-United States, 2004, 54 MORBIDITY & MORTALITY
WKLY. REP. 297, 300 (2005), available at http://www.cdc.gov/mmwr/PDF/wk/mm5412.pdf.
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and 90% believed that PREPs conferred less health risk.7 The truth is that even the
tobacco industry concedes that there is "no such thing as a safe cigarette."
8
But American consumers are now seeing the tobacco industry's marketing
expertise rise up once again as the industry works to promote supposed reduced
harm products, while smoking remains the nation's number one cause of
preventable death and the leading cause of cancer--of course lung cancer is the
number one cancer killer-not to mention heart disease. 9 The American Legacy
Foundation is restricted from lobbying. Therefore, in the language of the MSA it is
not possible for me to comment, in any substantive form, about the current bill in
Congress proposing Food & Drug Administration (FDA) regulation of tobacco. 10
The Foundation does, however, hope to play a role in allowing the drumbeat of
controversy and discussion to go on. Regardless of the fate of that particular bill,
whatever would come of it would inevitably be changed over time and so the law
would be only the beginning of a very long process, in the same way regulation has
evolved in other areas.
I would now like to give an operational definition of harm reduction. It refers
to policies or practices that lower risk along a continuum.11 They can be
interventions that society puts in place or they can be individually derived. They
can be medical, such as vaccines; they can be engineered, such as seatbelts. They
can also be activities that are substitutional, such as: soy instead of whole milk;
healthy oil instead of fat; non-alcoholic beverages instead of alcohol. If you're in
the public health community and you're looking at this problem, you absolutely
must consider harm reduction as a major focus because you understand that
universal cessation-absent some very unusual set of circumstances we may see
decades from now-is not likely to come about.
Before joining the American Legacy Foundation, I spent about twenty years
of my career working in the area of HIV/AIDS, particularly in the areas of
women's health and adolescent health. The field of HIV/AIDS was, and to a certain
extent still is, marked by very similar and very heated debates where sometimes it's
clear that some positions are purely political, but more often than not it's active
7. Saul Shiffman et al., UK Smokers' and Ex-smokers' Reactions to Cigarettes Promising Reduced
Risk, 102 ADDICTION 156, 157-58 (2006).
8. Philip Morris Int'l, Reduced Risk Products: "Safer" Cigarettes?,
http://www.philipmorrisintemational.com/PMINTL'pages/eng/busenv/Reduced-risk.asp (last visited
Jan. 8, 2008).
9. Am. Lung Ass'n., Facts About Lung Cancer,
http://www.lungusa.org/site/pp.asp?c=dvLUK900E&b=35427 (follow "What Causes Lung Cancer?"
hyperlink) (last visited Jan. 8, 2008); Am. Heart Ass'n, Cigarette Smoking and Cardiovascular Diseases,
http://www.americanheart.org/presenter.jhtml?identifier-4545 (last visited Jan. 8, 2008).
10. Family Smoking Prevention and Tobacco Control Act, S. 625, 110th Cong. (2007); H.R. 1108,
110th Cong. (2007).
11. See generally John S. Baer & Heather Brady Murch, Harm Reduction, Nicotine, and Smoking,
in HARM REDUCTION 122, 127-37 (G. Alan Marlatt ed., 1998).
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scientific debate about what will work best. Most of the time, the actual effect of
the policies that are being considered and put in place cannot be a priori predicted.
People seem to fall into the purist and pragmatist side of the equation and that
affects how they frame the issues. They also have to deal with whatever available
information they have to frame a risk-benefit equation; and very smart people can
frame that risk-benefit equation differently, particularly if part of the equation is
predicting what is, essentially, the unpredictable. I'm going to give one example
where it made sense that a certain action was going to have positive results from a
public health perspective, but it did not turn out that way.
Another example includes teen pregnancy, abstinence programs versus birth
control. I have my own opinion on those issues and I'm sure others do too. The one
I'm going to make a particular example of is called the Hierarchical Method of HIV
Risk Reduction. 12 In New York State, a number of people in the scientific
community were looking at the data on the use of spermicides and the impact on
the transmission of sexually transmitted diseases (STDs). 13 There was a large body
of evidence that associated not only condom use, but the use of gels, foam, and
spermicides, and diaphragms in combination with gels and spermicides, with a
markedly decreased risk of acquiring syphilis, Chlamydia, and a whole range of
sexually transmitted diseases.14 We all came together and said that the message that
we are putting out about HIV-that the only way to protect yourself is the male
condom-is probably problematic in the view of those data.
What developed is something called the Hierarchical Method of HIV
Prevention where there was basically a pyramid. The top of the pyramid was the
male condom, the second element in the pyramid was the female condom, below
that a diaphragm with additional gel, and finally gels and spermicides alone as a
last resort.15 The theory behind this hiearchy was based on the presumption that,
early-on in the epidemic, most sex acts that occurred around the world went
unprotected, and this, of course, was the driving force fueling the AIDS epidemic.
12. Erica L. Gollub et al., Achieving Safer Sex with Choice: Studying a Women's Sexual Risk
Reduction Hierarchy in an STD Clinic, 10 J. WOMEN'S HEALTH & GENDER-BASED MED. 771, 772
(2001).
13. See id; Michael J. Rosenberg & Erica L. Gollub, Commentary, Methods Women Can Use That
May Prevent Sexually Transmitted Disease, Including HIV, 82 AM. J. PUB. HEALTH 1473, 1474 (1992).
14. See, e.g., Rosenberg & Gollub supra note 13, at 1474-77; Robert L. Cook & Michael J.
Rosenberg, Do Spermicides Containing Nonoxynol-9 Prevent Sexually Transmitted Infections?: A Meta-
Analysis, 25 J. AM. SEXUALLY TRANSMITTED DISEASE ASS'N 144, 144-50 (1998), available at
http://www.stdjoumal.com/pt/re/std/fulltext.00007435-199803000-00007.htm.
15. Janneke van de Wijgert & Christiana Coggins, Microbicides to Prevent Heterosexual
Transmission of HIV: Ten Years Down the Road, BULL. OF EXPERIMENTAL TREATMENTS FOR AIDS
(San Francisco AIDS Found., S.F., Cal.), Spring 2002, at 23, 27.
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Eventually, after much debate and queasiness, the state health department bought
into this pyramid, which then became a disseminated model of education. 16
What were the arguments against it? One argument against it was very similar
to the smoking versus smokeless argument: "Goodness, if we do this, people who
would otherwise use the male condom in their sex acts are going to shift to this
easier thing; they're going to misunderstand it and think spermicides are just as
good as a male condom." There was a great deal of debate about it, but nonetheless
it became policy, practice, and public education before solid proof existed because
it seemed like an urgent health problem. What happened, as shown by a large scale
international study that was undertaken on the effects of spermicides on HIV
acquisition, was that not only were spermicides proven not to protect against HIV,
they actually increased the probability of HIV transmission.' 7 This is a classic
public health story where everyone felt that the mechanisms for the acquisition of
other STDs could be fungible to HIV and it turned out that they were wrong.
There are other examples: the whole issue of needle exchange and how our
nation has approached it in terms of our international HIV work, or how our nation
has approached condom use and abstinence. You have a large camp of individuals
from many different walks of life on both sides. Though the science may be clear,
when you apply it to public policy, different things happen-in terms of the U.S.
and the countries in which the U.S. spends its public health monies. Some favor
abstinence-only as a method of sexually transmitted disease prevention. Others
favor a combination of abstinence, monogamy, and condom use. We know that
abstinence-only does not work. As Alan Rosenfield, the Dean of the School of
Public Health at Columbia University, likes to say, "Abstinence is fine, as long as
you use it in moderation., 1 8 This debate is not new to public health. In essence, we
come down to the question: how do we balance human health with human nature?
We are a country that loves our freedoms. If you say, "Gee, maybe tobacco should
be banned," you are immediately labeled as "crazy." But the fact of the matter is
that if tobacco were a newly introduced product, it probably would never make it to
the market.
The American Legacy Foundation did a wonderful series of ads called
"Crazyworld," where it basically drew analogies between all sorts of other
consumer products that were found to lead to the deaths of three or four children
16. Erica L. Gollub, Choice is Empowering: Getting Strategic About Preventing HIV Infection in
Women, 32 INT'L FAM. PLAN. PERSP. 209, 210 (2006) (citing Policy Statement, NY State Dep't of
Health AIDS Institute, Methods of Personal Protection for Women to Reduce Transmission of HIV
Through Vaginal Intercourse (1992 & 2000)).
17. Spermicide May Increase HIV Risk During Anal Sex, REUTERS HEALTH, Sept. 26, 2002,
available at http://www.global-campaign.org/clientfiles/ReutersHealth.pdf.
18. Allan Rosenfeld, Dean, U. Colum. Sch. Pub. Health, Remarks at the Time Global Health
Summit 35 (Nov. 1, 2005), available at
http://www.time.com/time/2005/globalhealth/transcripts/I 10105aids.pdf
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and the aggressive steps that were followed to take these products off the market. 19
We all remember the spinach problem, and how it dominated the headlines. While
the spinach problem dominated the headlines, 1,200 people were dying every day
from tobacco-related deaths. E° So I said to myself, and I've said this to Philip
Morris also, "Keep making your product, just don't have a combustible version of
it." I don't think it's wrong, if you are thinking as a public health person, to try to
get as close as you can to a cigarette that does not combust and, thereby, markedly
reduces that risk yet delivers nicotine.
I am not only a former smoker, but a former nicotine gum addict, and a
former patch addict, and I used nicotine as a substitute, although substitution is not
technically a legitimate use. It took me a very long time until I could finally get off
the gum as well. I think the way we have handled medicinal nicotine, which does
provide an appropriate substitution for cigarettes, really does need to change
because it is too inaccessible for a variety of reasons. It doesn't have to be the only
product. I think the point has been made that the incentives are not in place to get
another product out to the market; for that matter, the incentives aren't in place for
the tobacco industry itself to try to aggressively move away from combustion.
One of the reasons that we do not see enlightened public health policy with
regard to tobacco, one of the primary reasons that the battle has been so long and
the efforts have been so arduous to have the right thing happen, as Christine
Gregoire (who served as the Attorney General during the MSA negotiations) noted:
The states and their politicians are addicted to the money.21 Most analyses have
shown that 50% of state legislators accept money from the tobacco industry. 2
There probably is an even higher percentage in Congress2 3 because these checks are
often automatically created. This is a major public policy problem. It is very
difficult to have enlightened public policy if the majority of our state legislators and
federal legislators-and they're not all doing it-are receiving tobacco industry
donations.
As public health professionals, we are here today to examine reduced harm
cigarettes or smokeless tobacco to see if they are truly viable steps along the
continuum for reducing risk. We know the toll that smoking takes on our nation is
19. See Press Release, Am. Legacy Found., truth® Launches New Crazyworld TV and Print
Creative (Sept. 18, 2003), available at http://www.americanlegacy.org/388.htm.
20. Am. Cancer Soc'y, Youth & Tobacco, Youth & Tobacco,
http://www.cancer.org/docroot/COM/content/divNorthwest/COM_5_IxYouthTobacco.asp (last
visited Feb. 14, 2008).
21. See Gordon Fairclough & Vanessa O'Connell, Co-Dependants: Once Tobacco Foes, States are
Hooked on Settlement Cash, WALL ST. J., Apr. 2, 2003, at Al.
22. Jill Abramson, Tobacco Industry Gave Big Where it Faced Attack, N.Y. TIMES, June 8, 1998, at
A16 ("Since Jan. 1, 1995, the tobacco industry donated about $1.8 million to state party central
committees in 26 states.").
23. See James Dao, Tobacco 's Contributions Reach Friend and Foe Alike, N.Y. TIMES MAG., May
3. 1998. at 46.
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high when 21% of the U.S. population currently smokes, leading to over 400,000
deaths every year. 24 In comparison, 2.3% of the population uses smokeless
tobacco.25 We know that smokeless tobacco is addictive and is strongly associated
with an increased risk of oral cancer,26 but I just learned that the estimated numbers
of those oral cancers are really far less than I originally understood. Of the 168,000
cancer deaths caused by tobacco,27 about 7,500 of those deaths were from oral
cancers, but the majority of those deaths were related to smoking and drinking as
opposed to smokeless tobacco.28 We do know that smokeless tobacco carries with it
a fairly small risk of heart disease. 29 The American Cancer Society recently
released a report announcing that cancer deaths continue to fall, 30 but there is
enormous cause for concern due to the fact that while both youth smoking for
eighth and tenth graders and adult smoking have stalled, they are no longer falling
as of last year.
3 1
We must stop and ask ourselves, are these products promising reduced harm
or are they really offering a different harm? Or are they offering something that
takes us along that continuum of reduced harm that is a hallmark of public health
practice? There are three issues that we are addressing when looking at the net
public health benefit, and these were highlighted in the Institute of Medicine (IOM)
report. First, will young people be induced to start (i.e., initiated into) using tobacco
when they otherwise would not have? Second, will people who would otherwise
quit tobacco, not quit? This certainly happened in the case of "light" cigarettes to a
substantial extent, and it was a fraud that allowed it to happen. Here, the issue is
whether such people would nonetheless be engaged in a behavior that carries
24. Am. Lung Ass'n, Smoking 101 Fact Sheet (2007),
http://www.lungusa.org/site/pp.asp?c=dvLUK900E&b=39853 (last visited Jan. 8, 2007).
25. Ctrs. for Disease Control & Prevention, Tobacco Use Among Adults - United States 2005, 55
MORBIDITY & MORTALITY WKLY. REP. 1145, 1145 (2006), available at
http://www.cdc.gov/MMWR/PDF/wk/mm5542.pdf.
26. Nat'l Cancer Inst., Smokeless Tobacco and Cancer: Questions and Answers,
http://www.cancer.gov/cancertopics/factsheet/Tobacco/smokeless (last visited Jan. 8, 2007).
27. AM. CANCER SOC'Y, CANCER FACTS AND FIGURES 2007 1 (2007), available at
http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf.
28. AM. CANCER SOC'Y, ORAL CAVITY AND OROPHARYNGEAL CANCER 6-7 (2007), available at
http://documents.cancer.org/5043.00/5043.00.pdf.
29. David T. Levy et al., The Relative Risks of a Low-Nitrosamine Smokeless Tobacco Product
Compared with Smoking Cigarettes: Estimates of a Panel of Experts, 13 CANCER EPIDEMIOLOGY
BIOMARKERS & PREVENTION 2035, 2038 (2004).
30. AM. CANCER SOC'Y, supra note 27, atpassim.
31. LLOYD D. JOHNSTON ET AL., NAT'L INST. ON DRUG ABUSE, MONITORING THE FUTURE:
NATIONAL RESULTS ON ADOLESCENT DRUG USE 39-41 (2007), available at
http://www.monitoringthefuture.org/pubs/monographs/overview2006.pdf. Contra David Mendez &
Kenneth E. Warner, Adult Cigarette Smoking Prevalence: Declining as Expected (Not as Desired), 94
AM. J. PUB. HEALTH 251, 251 (2004).
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substantially less risk than the combustible cigarette. Third, will people who have
successfully quit smoking return to using a tobacco-related product?
32
Just to be a little of a provocateur, I would say that if I had 100 of my public
health colleagues in the room with me who did not work at all in the tobacco field,
and they reviewed the evidence, probably 80 of the 100 would say smokeless
tobacco is a viable alternative to combustible tobacco. I know, in a sense, that is
unacceptable in many circles, but I think the reality is-and this has come up many
times when public health problems are being analyzed in terms of their net public
health benefit-many times we overestimate the probability of certain risks
occurring. There are ways, in theory, to try to estimate those risks, and I know there
are papers out there that have tried to look at this issue, but at the end of the day,
it's all about risk-benefit ratios.
I will just take a brief moment to discuss the concept of a ban. Some of you
may know one of the leading national health associations in the country-I won't
name which, because it decided not to do it-was going to announce its belief that
tobacco should be banned. A number of people talked the association out of it. In
fact, consumer products that cause harm generally are banned. And this is a product
that kills 50% of the people who use it as directed over the course of their lives. I
just want to share some thoughts that you might hear in public policy health circles,
but not in tobacco circles. When I'm on the road speaking to groups where there are
many young people, the most common question I am asked by adolescents is "If
it's so bad, why isn't it banned?" That is also one of the top five questions I am
asked by adults.
There is a disconnect for the man or woman on the street with the policy we
have pursued. For example (although it's politically nonviable), I think if there was
an effort to ban the combustible cigarettes, it would get a lot of momentum. It
would certainly get a lot of legs in the public health community. Maybe not in the
tobacco community per se, but politically, given the strength of the industry that I
described earlier (economically and psychosocially) it is very unlikely that a ban
will happen in this country. The issue with a ban-and I'm not promoting a ban,
but doing an intellectual exercise-is the example that's always raised: prohibition.
There is a big difference between a drug that is substantially mind altering and
confers a set of reactions in a person and a substance that largely relieves your
withdrawal symptoms. Most people say smoking calms their nerves because as
soon as they finish a cigarette, they start again on a cycle of withdrawal.
Essentially, there is a disconnect in terms of how we handle consumer products,
and there is a disconnect in the reasons we dredge up for why we don't move
toward much more aggressive regulation of this particular product.
32. See INST. OF MED., CLEARING THE SMOKE 31-34 (Kathleen Stratton et al. eds., 2001).
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To me, it's largely the political context that is the driving force, because it's
shifting our expectations. If you don't think it can be done, then you don't spend
much time doing it. I am in the camp that you need to start somewhere and you
need to do something. At the end of the day, I do embrace the bottom line that
came out in the IOM report: we do not have the evidence before us now that
PREPs, as opposed to smokeless tobacco products, represent any kind of reduced
33 34harm.33 The report also weighed in on regulation and said that the time is now.
The IOM made the very important point that the net public health impact of
reduced harm products is unknown. 35 The IOM's path is going to be a very time
consuming and scientifically rigorous path to follow. While we're on that path, it
would be a good idea for us to be on another path considering the steps that would
bring us closer to harm reduction for everyone, not only in this country, but around
the world, given the fact that the United States is one of the lead (if not the lead)
exporters of the most deadly drug known to man.36 It is now causing and will
continue to cause enormous death and disability.
For argument's sake, what could be done with the acquisition of no new
knowledge, just by implementing the policies that we now know work? More
importantly, what is the price for not doing so? These questions should drive our
discussions about PREPs and, frankly, about smokeless tobacco, and our
discussions about the current regulatory environment that does not allow innovative
nicotine delivery devices to get out there. The reality is that, in the United States,
the overwhelming majority of these 45 million Americans who still smoke are
lower-middle-income and low-income. 37 Their health plans do not cover nicotine
gum, and it's frequently priced at the point of purchase at $70 a box. 38 Depending
on how much you smoke, that may last you two weeks, or it might last you a week,
or in some crazy cases, maybe three days. So I think we really need to consider,
just in terms of harm reduction, making that product more accessible to individuals
so that they may choose to use that product in lieu of smoking. Now, I know that
evidence suggests that cutting back on smoking after many years of smoking has a
very negligible impact on risk, and I am not arguing that nicotine therapy should be
used in lieu of smoking while you are still smoking. I do, however, think that it is
33. Id. at 5.
34. Id. at 6.
35. Id.
36. See ERIC N. LINDBLOM, FALSE FRIENDS: THE U.S. CIGARETTE COMPANIES' BETRAYAL OF
AMERICAN TOBACCO FARMERS, at v (1999).
37. MEG GALLOGLY, CAMPAIGN FOR TOBACCO-FREE KIDS, TOBACCO AND SOCIOECONOMIC
STATUS I (2004), http://tobaccofreekids.org/research/factsheets/pdf/0260.pdf.
38. Even if tobacco-dependence treatments are offered by a state's Medicaid plans, many Medicaid
beneficiaries do not seek such treatment because they are not aware of the coverage options. Sara B.
McMenamin et al., Physician and Enrollee Knowledge of Medicaid Coverage for Tobacco Dependence
Treatments, 26 AM. J. PREVENTIVE MED. 99, 99 (2004).
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insufficiently available and that's a very important harm-reduction issue that needs
to be taken up-not only the price, but the packaging of the product itself.
In closing, I am delighted to be here and share some of my thoughts with you.
I am also just delighted that the Health and Human Service's Healthy People 2010
goals related to smoking, which are the reduction of adult smoking to 12% and
youth smoking to 16%, 39 were put in place in the year 2000 and are moving at the
most rapid pace. Although we've had a recent stall, the reduction in smoking in the
United States since 1964 is by all accounts and in the views of the broad public
health community outside of tobacco control, one of the greatest public health
victories that has ever occurred.4 ° I just hope that we altogether redouble our efforts
to continue such a public health victory and drive us all the way home to the
eradication of tobacco use, the eradication of an epidemic. Thank you.
39. U.S. DEP'T OF HEALTH & HUMAN SERVS., HEALTHY PEOPLE 2010: VOLUME II, at 27-10, 27-12
(2000), available at http://www.healthypeople.gov/Document/pdf/Volume2/27Tobacco.pdf
40. See Ctrs. for Disease Control & Prevention, Tobacco Use-United States, 1900-1999, 48
MORTALITY & MORBIDITY WKLY. REP. 986, 988 (1999), available at
http://www.cdc.gov/mmwr/PDF/wk/mm4843.pdf.
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